In this issue:
Survival with sentinel lymph node vs full axillary dissection
Value of chemotherapy for ILC and IDC
Women aged <35 years in TEXT and SOFT
When to initiate OFS when chemotherapy is also given?
Abemaciclib + fulvestrant for HR+/HER2− advanced disease
Low-fat diet lowers risk of death after breast cancer
Ipatasertib + paclitaxel promising in metastatic TNBC
Adding irosustat to first-line AIs benefits ER+ disease
Etirinotecan pegol shows promise in brain metastases
Sequential vs concurrent neoadjuvant chemotherapy in non-metastatic disease
Please login below to download this issue (PDF)